Although the prostate-specific antigen (PSA) blood test is a widely used screening tool allowing for earlier diagnosis, it possesses some limitations in identifying patients with significant PCa or at the high risk of progression [3]. The gene discussed is KLK3; the disease is posterior cortical atrophy.